SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-18-000018
Filing Date
2018-11-08
Accepted
2018-11-08 16:38:29
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q denali2018q310q.htm 10-Q 1490908
2 EXHIBIT 10.1 exhibit101q32018.htm EX-10.1 25270
3 EXHIBIT 10.2 exhibit102q32018.htm EX-10.2 27284
4 EXHIBIT 31.1 exhibit311q32018.htm EX-31.1 12470
5 EXHIBIT 31.2 exhibit312q32018.htm EX-31.2 12437
6 EXHIBIT 32.1 exhibit321q32018.htm EX-32.1 6689
7 EXHIBIT 32.2 exhibit322q32018.htm EX-32.2 7226
  Complete submission text file 0001714899-18-000018.txt   6781271

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dnli-20180930.xml EX-101.INS 1364743
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20180930.xsd EX-101.SCH 52310
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20180930_cal.xml EX-101.CAL 60129
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20180930_def.xml EX-101.DEF 281180
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20180930_lab.xml EX-101.LAB 650292
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20180930_pre.xml EX-101.PRE 404388
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 181170216
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1